Chapter/Section Purchase

1 Study Coverage
1.1 Mesalazine Product Introduction
1.2 Market by Type
1.2.1 Global Mesalazine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ? 97 %
1.2.3 Purity ? 98 %
1.2.4 Purity ? 99 %
1.3 Market by Application
1.3.1 Global Mesalazine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Pellet and Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mesalazine Sales Estimates and Forecasts 2017-2028
2.2 Global Mesalazine Revenue Estimates and Forecasts 2017-2028
2.3 Global Mesalazine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mesalazine Sales by Region
2.4.1 Global Mesalazine Sales by Region (2017-2022)
2.4.2 Global Sales Mesalazine by Region (2023-2028)
2.5 Global Mesalazine Revenue by Region
2.5.1 Global Mesalazine Revenue by Region (2017-2022)
2.5.2 Global Mesalazine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mesalazine Sales by Manufacturers
3.1.1 Global Top Mesalazine Manufacturers by Sales (2017-2022)
3.1.2 Global Mesalazine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mesalazine in 2021
3.2 Global Mesalazine Revenue by Manufacturers
3.2.1 Global Mesalazine Revenue by Manufacturers (2017-2022)
3.2.2 Global Mesalazine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mesalazine Revenue in 2021
3.3 Global Mesalazine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mesalazine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mesalazine Sales by Type
4.1.1 Global Mesalazine Historical Sales by Type (2017-2022)
4.1.2 Global Mesalazine Forecasted Sales by Type (2023-2028)
4.1.3 Global Mesalazine Sales Market Share by Type (2017-2028)
4.2 Global Mesalazine Revenue by Type
4.2.1 Global Mesalazine Historical Revenue by Type (2017-2022)
4.2.2 Global Mesalazine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mesalazine Revenue Market Share by Type (2017-2028)
4.3 Global Mesalazine Price by Type
4.3.1 Global Mesalazine Price by Type (2017-2022)
4.3.2 Global Mesalazine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mesalazine Sales by Application
5.1.1 Global Mesalazine Historical Sales by Application (2017-2022)
5.1.2 Global Mesalazine Forecasted Sales by Application (2023-2028)
5.1.3 Global Mesalazine Sales Market Share by Application (2017-2028)
5.2 Global Mesalazine Revenue by Application
5.2.1 Global Mesalazine Historical Revenue by Application (2017-2022)
5.2.2 Global Mesalazine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mesalazine Revenue Market Share by Application (2017-2028)
5.3 Global Mesalazine Price by Application
5.3.1 Global Mesalazine Price by Application (2017-2022)
5.3.2 Global Mesalazine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mesalazine Market Size by Type
6.1.1 North America Mesalazine Sales by Type (2017-2028)
6.1.2 North America Mesalazine Revenue by Type (2017-2028)
6.2 North America Mesalazine Market Size by Application
6.2.1 North America Mesalazine Sales by Application (2017-2028)
6.2.2 North America Mesalazine Revenue by Application (2017-2028)
6.3 North America Mesalazine Market Size by Country
6.3.1 North America Mesalazine Sales by Country (2017-2028)
6.3.2 North America Mesalazine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Mesalazine Market Size by Type
7.1.1 Europe Mesalazine Sales by Type (2017-2028)
7.1.2 Europe Mesalazine Revenue by Type (2017-2028)
7.2 Europe Mesalazine Market Size by Application
7.2.1 Europe Mesalazine Sales by Application (2017-2028)
7.2.2 Europe Mesalazine Revenue by Application (2017-2028)
7.3 Europe Mesalazine Market Size by Country
7.3.1 Europe Mesalazine Sales by Country (2017-2028)
7.3.2 Europe Mesalazine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mesalazine Market Size by Type
8.1.1 Asia Pacific Mesalazine Sales by Type (2017-2028)
8.1.2 Asia Pacific Mesalazine Revenue by Type (2017-2028)
8.2 Asia Pacific Mesalazine Market Size by Application
8.2.1 Asia Pacific Mesalazine Sales by Application (2017-2028)
8.2.2 Asia Pacific Mesalazine Revenue by Application (2017-2028)
8.3 Asia Pacific Mesalazine Market Size by Region
8.3.1 Asia Pacific Mesalazine Sales by Region (2017-2028)
8.3.2 Asia Pacific Mesalazine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Mesalazine Market Size by Type
9.1.1 Latin America Mesalazine Sales by Type (2017-2028)
9.1.2 Latin America Mesalazine Revenue by Type (2017-2028)
9.2 Latin America Mesalazine Market Size by Application
9.2.1 Latin America Mesalazine Sales by Application (2017-2028)
9.2.2 Latin America Mesalazine Revenue by Application (2017-2028)
9.3 Latin America Mesalazine Market Size by Country
9.3.1 Latin America Mesalazine Sales by Country (2017-2028)
9.3.2 Latin America Mesalazine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Mesalazine Market Size by Type
10.1.1 Middle East and Africa Mesalazine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mesalazine Revenue by Type (2017-2028)
10.2 Middle East and Africa Mesalazine Market Size by Application
10.2.1 Middle East and Africa Mesalazine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mesalazine Revenue by Application (2017-2028)
10.3 Middle East and Africa Mesalazine Market Size by Country
10.3.1 Middle East and Africa Mesalazine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mesalazine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 PharmaZell
11.1.1 PharmaZell Corporation Information
11.1.2 PharmaZell Overview
11.1.3 PharmaZell Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 PharmaZell Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 PharmaZell Recent Developments
11.2 Syntese A/S
11.2.1 Syntese A/S Corporation Information
11.2.2 Syntese A/S Overview
11.2.3 Syntese A/S Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Syntese A/S Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Syntese A/S Recent Developments
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Corporation Information
11.3.2 Cambrex Corporation Overview
11.3.3 Cambrex Corporation Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cambrex Corporation Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cambrex Corporation Recent Developments
11.4 Divis Laboratories
11.4.1 Divis Laboratories Corporation Information
11.4.2 Divis Laboratories Overview
11.4.3 Divis Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Divis Laboratories Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Divis Laboratories Recent Developments
11.5 Chemi SpA
11.5.1 Chemi SpA Corporation Information
11.5.2 Chemi SpA Overview
11.5.3 Chemi SpA Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chemi SpA Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chemi SpA Recent Developments
11.6 Ipca Laboratories
11.6.1 Ipca Laboratories Corporation Information
11.6.2 Ipca Laboratories Overview
11.6.3 Ipca Laboratories Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ipca Laboratories Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ipca Laboratories Recent Developments
11.7 Hangzhou Brother
11.7.1 Hangzhou Brother Corporation Information
11.7.2 Hangzhou Brother Overview
11.7.3 Hangzhou Brother Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hangzhou Brother Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hangzhou Brother Recent Developments
11.8 Lianyungang Fengheng Biopharm
11.8.1 Lianyungang Fengheng Biopharm Corporation Information
11.8.2 Lianyungang Fengheng Biopharm Overview
11.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lianyungang Fengheng Biopharm Recent Developments
11.9 Lasa Loboratory
11.9.1 Lasa Loboratory Corporation Information
11.9.2 Lasa Loboratory Overview
11.9.3 Lasa Loboratory Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Lasa Loboratory Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lasa Loboratory Recent Developments
11.10 Corden Pharma Bergamo
11.10.1 Corden Pharma Bergamo Corporation Information
11.10.2 Corden Pharma Bergamo Overview
11.10.3 Corden Pharma Bergamo Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Corden Pharma Bergamo Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Corden Pharma Bergamo Recent Developments
11.11 Erregierre SpA
11.11.1 Erregierre SpA Corporation Information
11.11.2 Erregierre SpA Overview
11.11.3 Erregierre SpA Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Erregierre SpA Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Erregierre SpA Recent Developments
11.12 CTX Lifescience
11.12.1 CTX Lifescience Corporation Information
11.12.2 CTX Lifescience Overview
11.12.3 CTX Lifescience Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CTX Lifescience Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CTX Lifescience Recent Developments
11.13 Ishita Active Pharma Ingredients
11.13.1 Ishita Active Pharma Ingredients Corporation Information
11.13.2 Ishita Active Pharma Ingredients Overview
11.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ishita Active Pharma Ingredients Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ishita Active Pharma Ingredients Recent Developments
11.14 YC Biotech (Jiangsu)
11.14.1 YC Biotech (Jiangsu) Corporation Information
11.14.2 YC Biotech (Jiangsu) Overview
11.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 YC Biotech (Jiangsu) Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 YC Biotech (Jiangsu) Recent Developments
11.15 Xinxiang Tianfeng Fine Chemical
11.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
11.15.2 Xinxiang Tianfeng Fine Chemical Overview
11.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mesalazine Industry Chain Analysis
12.2 Mesalazine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mesalazine Production Mode & Process
12.4 Mesalazine Sales and Marketing
12.4.1 Mesalazine Sales Channels
12.4.2 Mesalazine Distributors
12.5 Mesalazine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mesalazine Industry Trends
13.2 Mesalazine Market Drivers
13.3 Mesalazine Market Challenges
13.4 Mesalazine Market Restraints
14 Key Findings in The Global Mesalazine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer